Artificial intelligence-driven volumetric CT outcome score in cystic fibrosis: longitudinal and multicenter validation with/without modulators treatment
Author:
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s00330-024-11019-5.pdf
Reference46 articles.
1. Cromwell EA, Ostrenga JS, Todd JV et al (2023) Cystic fibrosis prevalence in the United States and participation in the Cystic Fibrosis Foundation Patient Registry in 2020. J Cyst Fibros 22:436–442
2. Middleton PG, Mall MA, Dřevínek P et al (2019) Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele. N Engl J Med 381:1809–1819
3. Heltshe SL, Cogen J, Ramos KJ, Goss CH (2017) Cystic fibrosis: the dawn of a new therapeutic era. Am J Respir Crit Care Med 195:979–984
4. Tiddens HAWM, Kuo W, van Straten M, Ciet P (2018) Paediatric lung imaging: the times they are a-changin’. Eur Respir Rev 27:170097
5. Ramsey BW (2007) Use of lung imaging studies as outcome measures for development of new therapies in cystic fibrosis. Proc Am Thorac Soc 4:359–363
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3